Business > CASE STUDY > Harvard Case Solutions For: Genentech capacity Planning (All)
Harvard Case Solutions For: Genentech capacity Planning
Document Content and Description Below
While facilitating a complex clinical approval process over the next two to three years for a family of new cancer drugs, Genentech must develop a long-term capacity plan for a major class of new canc... er products. Adding to the complexity and uncertainty is the fact that the lead time for planning, building, and certifying a new $600 million plus production-scale facility is five years. In addition, ensuring that the best process technology is incorporated into such a new plant makes the task facing David Ebersman, the senior vice-president of products operations, and his management team a daunting one. Frames the issues Ebersman and his team face and outlines the approach to date. [Show More]
Last updated: 2 years ago
Preview 1 out of 11 pages
Buy this document to get the full access instantly
Instant Download Access after purchase
Buy NowInstant download
We Accept:
Reviews( 0 )
$45.00
Can't find what you want? Try our AI powered Search
Document information
Connected school, study & course
About the document
Uploaded On
Dec 09, 2021
Number of pages
11
Written in
Additional information
This document has been written for:
Uploaded
Dec 09, 2021
Downloads
0
Views
32
